Arc Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Therapy to be supported by newly awarded $1M grant from Michael J. Fox FoundationEINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a publication in Nature Medicine using investigational ONWARD ARC Therapy to address gait challenges related to Parkinson’s disea

This study on the Global Volumetric Arc Therapy Market promises exceptional information on a range of growth drivers. The study involves exhaustive research by skilled analysts covering a plethora of growth factors revolving around the Volumetric Arc Therapy market across the assessment period of 2021-2029. The stud...

ONWARD, formerly known as GTX Medical, announced the enrollment of the first patient in a pivotal trial in the U.S. evaluating its ARC Therapy. The pivotal trial, known as Up-LIFT, will assess the safety and effectiveness of ARC Therapy in restoring hand and arm function in people with spinal cord injury. ONWARD is focused on developing and commercialising innovative therapies to facilitate functional recovery of people with spinal cord injury. Driven by a mission to restore movement, independence, and health in people with spinal cord injury, ONWARD  developed the ARC Therapy, delivered by ...